COVID-19 disruption and rebound of respiratory syncytial virus hospital burden in Australia: a national interrupted time-series analysis Read more about COVID-19 disruption and rebound of respiratory syncytial virus hospital burden in Australia: a national interrupted time-series analysis1 view
Respiratory syncytial virus disease burden and evidence gaps in Australia before immunisation introduction: a retrospective population-based study using 2016-2019 hospitalisation and 2023 laboratory surveillance data Read more about Respiratory syncytial virus disease burden and evidence gaps in Australia before immunisation introduction: a retrospective population-based study using 2016-2019 hospitalisation and 2023 laboratory surveillance data2 views
Impact and effectiveness of Australia's 2025 hybrid RSV immunisation program: results from the PAEDS-FluCAN Network Read more about Impact and effectiveness of Australia's 2025 hybrid RSV immunisation program: results from the PAEDS-FluCAN Network16 views
Respiratory syncytial virus transmission in closed community settings that include children: a systematic review and meta-analysis Read more about Respiratory syncytial virus transmission in closed community settings that include children: a systematic review and meta-analysis9 views
ATAGI Targeted Review 2024: immunisation strategies for prevention and control of respiratory syncytial virus disease in Australia Read more about ATAGI Targeted Review 2024: immunisation strategies for prevention and control of respiratory syncytial virus disease in Australia9 views
Unequal access: Respiratory syncytial virus vaccine uptake by socioeconomic status among older adults in Australia Read more about Unequal access: Respiratory syncytial virus vaccine uptake by socioeconomic status among older adults in Australia22 views
Respiratory syncytial virus epidemiology and effectiveness of infant nirsevimab: 2024 results from the Australian Sentinel Hospital Network (FluCAN-PAEDS) Read more about Respiratory syncytial virus epidemiology and effectiveness of infant nirsevimab: 2024 results from the Australian Sentinel Hospital Network (FluCAN-PAEDS)10 views
A population-representative serosurvey estimating vaccine-induced immunity against measles, rubella, hepatitis B and severe acute respiratory syndrome coronavirus 2 in Timor-Leste Read more about A population-representative serosurvey estimating vaccine-induced immunity against measles, rubella, hepatitis B and severe acute respiratory syndrome coronavirus 2 in Timor-Leste28 views
Short term safety profile of respiratory syncytial virus vaccine in adults aged ≥ 60 years in Australia Read more about Short term safety profile of respiratory syncytial virus vaccine in adults aged ≥ 60 years in Australia44 views
Nirsevimab: alleviating the burden of RSV morbidity in young children Read more about Nirsevimab: alleviating the burden of RSV morbidity in young children47 views
